Treatment of neurodegenerative diseases
undefined CHRISTOPHER HOVENS, undefined NIALL CORCORAN
Published : 2007
The present invention relates to the use of selenate or a pharmaceutically acceptable salt thereof in methods and compositions for enhancing the activity of the protein phosphatase PP2A. Methods of reducing phosphorylation of tau protein, inhibiting activity of GSK3 and treating or preventing neurodegenerative diseases are also described.